Translating Comparative Effectiveness Into Practice: The Case of Diabetes Medications
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
BACKGROUND: In recent years, there has been significant interest and investment in conducting comparative effectiveness research (CER) of medical treatments to improve the quality of care and reduce costs. The Agency for Healthcare Research and Quality (AHRQ) has been leading this effort and has invested a significant amount of resources to advance CER. However, little is known about translating the findings from CER into routine practice such that it provides value to the patients, clinicians, and the healthcare system. METHODS: We present the role of shared decision making for patient-centered CER translation and its application to diabetes medications. CER of oral diabetes medications suggests that all medications are similar in their effects on glycemic control, but there is variability in side-effects, which may affect medication adherence and treatment intensification. Shared decision making, facilitated by tools such as decision aids, may enhance the quality of diabetes care by activating patients, enhancing the patient-clinician communication, and improving uptake and adherence to the medication that is determined to be consistent with patients' goals, values, and preferences. We describe the iterative, multidisciplinary process for developing and testing a diabetes medication decision aid, and examine the implications for CER translation. RESULTS: In our pilot study we found the decision aid to be acceptable to patients and providers and effective for knowledge translation; however, it did not impact short-term outcomes. DISCUSSION: Our pilot trial found that decision aids enhanced the discussion about diabetes medications without any adverse effects on the outcomes. Further issues related to the use of decision aids to translate CER need to be addressed in larger trials to understand the effectiveness and efficiency of translating evidence into routine practice in unique contexts of patients, providers, and healthcare systems.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Meaning of Translational Research and Why It Matters
Woolf, S. H. (2008) · JAMA · doi:10.1001/jama.2007.26 · Cited by 1,910
Practice-based research--“Blue Highways” on the NIH roadmap
Westfall, J. M., Mold, J., & Fagnan, L. (2007) · JAMA · doi:10.1001/jama.297.4.403 · Cited by 1,209
Weingarten, S. R. (2002) · BMJ · doi:10.1136/bmj.325.7370.925 · Cited by 735
Schmittdiel, J. A., Uratsu, C. S., Karter, A. J., Heisler, M., Subramanian, U., Mangione, C. M., & Selby, J. V. (2008) · Journal of General Internal Medicine · doi:10.1007/s11606-008-0554-8 · Cited by 239 · cited 1×
“Recent evidence suggests that lack of intensification of diabetes treatment in a timely manner may be an explanatory factor.(11) The decision to intensify treatment may be affected by many factors, including likelihood of patient adherence, competing demands on the patients’ time, or provider knowledge and attitudes.”
BackgroundFinding New Treatments for Diabetes — How Many, How Fast . . . How Good?
Nathan, D. M. (2007) · New England Journal of Medicine · doi:10.1056/nejmp068294 · Cited by 216 · cited 1×
“There have been significant advances in the agents available for the management of glycemic control for diabetes patients; however, it is difficult to compare these agents because there are so many individual drugs and drug classes and so little synthesis of what is known.(6) The sheer volume and contradictory nature…”
Background
Cited by
Inzucchi, S. E., Bergenstal, R. M., Buse, J. B., Diamant, M., Ferrannini, E., Nauck, M., Peters, A. L., Tsapas, A., Wender, R., & Matthews, D. R. (2012) · Diabetologia · doi:10.1007/s00125-012-2534-0 · Cited by 3,919
Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach
Inzucchi, S. E., Bergenstal, R. M., Buse, J. B., Diamant, M., Ferrannini, E., Nauck, M., Peters, A. L., Tsapas, A., Wender, R., & Matthews, D. R. (2012) · Diabetes Care · doi:10.2337/dc12-0413 · Cited by 3,207
Légaré, F., & Witteman, H. O. (2013) · Health Affairs · doi:10.1377/hlthaff.2012.1078 · Cited by 783
Concannon, T. W., Fuster, M., Saunders, T., Patel, K., Wong, J. B., Leslie, L. K., & Lau, J. (2014) · Journal of General Internal Medicine · doi:10.1007/s11606-014-2878-x · Cited by 468
Eliciting the Patient’s Agenda- Secondary Analysis of Recorded Clinical Encounters
Singh Ospina, N., Phillips, K. A., Rodriguez-Gutierrez, R., Castaneda-Guarderas, A., Gionfriddo, M. R., Branda, M. E., & Montori, V. M. (2019) · Journal of General Internal Medicine · doi:10.1007/s11606-018-4540-5 · Cited by 297
Self-citation
Metadata
- Authors
- Shah, N. D., Mullan, R. J., Breslin, M., Yawn, B. P., Ting, H. H., & Montori, V. M.
- Venue
- Medical Care
- Published
- 2010-06
- Volume
- 48
- Issue
- 6
- Pages
- S153-S158
- ISSN
- 0025-7079 (ISSN-L)
- OpenAlex
- W1983720808
- Cited by
- 48
- References
- 5
- FWCI
- 9.49
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Translating Comparative Effectiveness Into Practice: The Case of Diabetes Medications. https://app.cochat.ai/papers/10.1097/mlr.0b013e3181d5956c
- The paper
- Shah, N. D., Mullan, R. J., Breslin, M., Yawn, B. P., Ting, H. H., & Montori, V. M. (2010). Translating Comparative Effectiveness Into Practice: The Case of Diabetes Medications. Medical Care. https://doi.org/10.1097/mlr.0b013e3181d5956c
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.